Clinical trials
Terminated Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
242 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 10 |
| 2006 | 9 |
| 2007 | 19 |
| 2008 | 21 |
| 2009 | 15 |
| 2010 | 7 |
| 2011 | 15 |
| 2012 | 13 |
| 2013 | 13 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 9 |
| 2017 | 15 |
| 2018 | 14 |
| 2019 | 14 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 9 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 242 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Mental Health (NIMH) | 9 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 |
| AstraZeneca | 7 |
| Hôpital le Vinatier | 6 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 6 |
| University Hospital, Strasbourg, France | 6 |
| Denovo Biopharma LLC | 5 |
| H. Lundbeck A/S | 5 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 5 |
| Yale University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 242 |
| Psychotic Disorders | 65 |
| Bipolar Disorder | 9 |
| Hallucinations | 8 |
| Mental Disorders | 8 |
| Cognitive Dysfunction | 7 |
| Obesity | 7 |
| Metabolic Syndrome | 5 |
| Cognition Disorders | 4 |
| Weight Gain | 4 |
Trials
Showing 76 to 100 of 242. Each trial links to its page on Pharma Observatory.
142 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.